Improving the outcome of childhood pulmonary arterial hypertension: The effect of Bosentan in the setting of a dedicated pulmonary hypertension clinic

Journal of the American College of Cardiology

Volumn 46, Issue 4, 2005, Pages 705-706

  Adatia, Ian ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; PROSTANOID;

DRUG EFFECT; HEART AFTERLOAD; HEART CATHETERIZATION; HEART RIGHT VENTRICLE; HUMAN; NOTE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; WORLD HEALTH ORGANIZATION;

EID: 23644440081     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.05.038     Document Type: Editorial

References (9)

1. Z. Deng, J.H. Morse, S.L. Slager Familial primary pulmonary hypertension (Gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene Am J Hum Genet 67 2000 737 744
2. R.C. Trembath, J.R. Thomson, R.D. Machado Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia N Engl J Med 345 2001 325 334
3. J.R. Thompson, R.D. Machado, M.W. Pauciulo Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family J Med Genet 37 2000 741 745
4. R.E. Harrison, R. Berger, S.G. Haworth Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood Circulation 111 2005 435 441
5. V.V. McLaughlin, A. Shillington, S. Rich Survival in primary pulmonary hypertension the impact of epoprostenol therapy Circulation 106 2002 1477 1482
6. R.J. Barst, D. Ivy, J. Dingemanse Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension Clin Pharmacol Ther 73 2003 372 382
7. Rosenzweig EB, Ivy DD, Widlitz A, et al. Effects of long-term bosentan in children with pulmonary arterial hypertension. J Am Coll Cardiol 2005;46:697-704.
8. J. Sandoval, O. Bauerle, A. Gomez, A. Palomar, M.L.M. Guerra, M.E. Furuya Primary pulmonary hypertension in children: clinical characterization and survival J Am Coll Cardiol 25 1995 466 474
9. J. Sandoval, O. Bauerle, A. Palomar Survival in primary pulmonary hypertension validation of a prognostic equation Circulation 89 1994 1733 1744